Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00469-0/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz-9RbhHtF2smS9Q9g4-yRL0GMWE8IejQ2eiM_CLpZQsC1AnJ4CtaM6kiT_pSGqdGwd0luvpG8Xh5kD6gnn3d1ZPnOrFsaQ&_hsmi=301365793&utm_content=301365793&utm_source=hs_email